Advancing the Management of Life-Threatening Bleeding in the Anticoagulated Patient: Reversal Approaches in the Emergency Department

Monday, October 17, 2022, 12:00 AM - Tuesday, October 17, 2023, 11:00 PM

AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)


This program discusses the role of reversal agents in the presence of life-threatening bleeds while on an anticoagulant. It focuses on managing the anticoagulated patient with life-threatening intracranial bleeding, gastrointestinal bleeding, and post-traumatic bleeding in the Emergency Department.

To register, please go to: on www.MedEdOnTheGo.com or https://www.emcreg.org/emcreg-on-the-go

There is no registration fee.

1. Discuss the risk factors for DOAC-related bleeding, as well as the appropriate diagnosis and monitoring of a life-threatening bleed, along with the associated need for treatment with a reversal strategy, particularly for ICH.
2. Identify the appropriate diagnostic approaches to upper and lower GI bleeding, describe the essential treatment and specialist interventions, and implement treatment.
3. Review the clinical applications and recommendations associated with repletion and reversal agents for DOACs, based on an understanding of the mechanism of action, benefits, risks, dosing, monitoring, and management of these agents including anti-vitamin K therapies such as coumadin, or specific di

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati, EMCREGG International and _TotalCME, Inc.
The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credits commensurate with the extent of their participation in the activity.


The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development. 

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests) over the last 24-months. All relevant relationships have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

No faculty are available for this activity at this time.

This activity is supported by an independent educational grant from AstraZeneca.